nodes	percent_of_prediction	percent_of_DWPC	metapath
Carfilzomib—PSMB8—pancreas—gallbladder cancer	0.029	0.107	CbGeAlD
Carfilzomib—PSMB10—liver—gallbladder cancer	0.0286	0.105	CbGeAlD
Carfilzomib—PSMB5—pancreas—gallbladder cancer	0.0256	0.0944	CbGeAlD
Carfilzomib—PSMB1—pancreas—gallbladder cancer	0.0224	0.0825	CbGeAlD
Carfilzomib—PSMB10—lymph node—gallbladder cancer	0.022	0.0809	CbGeAlD
Carfilzomib—PSMB2—pancreas—gallbladder cancer	0.0218	0.0805	CbGeAlD
Carfilzomib—PSMB8—liver—gallbladder cancer	0.0185	0.068	CbGeAlD
Carfilzomib—PSMB5—liver—gallbladder cancer	0.0163	0.06	CbGeAlD
Carfilzomib—PSMB1—liver—gallbladder cancer	0.0142	0.0525	CbGeAlD
Carfilzomib—PSMB8—lymph node—gallbladder cancer	0.0141	0.0521	CbGeAlD
Carfilzomib—PSMB2—liver—gallbladder cancer	0.0139	0.0512	CbGeAlD
Carfilzomib—PSMB5—lymph node—gallbladder cancer	0.0125	0.046	CbGeAlD
Carfilzomib—PSMB1—lymph node—gallbladder cancer	0.0109	0.0402	CbGeAlD
Carfilzomib—PSMB2—lymph node—gallbladder cancer	0.0107	0.0393	CbGeAlD
Carfilzomib—ABCB1—epithelium—gallbladder cancer	0.00375	0.0138	CbGeAlD
Carfilzomib—ABCB1—pancreas—gallbladder cancer	0.00334	0.0123	CbGeAlD
Carfilzomib—ABCB1—liver—gallbladder cancer	0.00212	0.00782	CbGeAlD
Carfilzomib—PSMB10—Adaptive Immune System—ERBB4—gallbladder cancer	0.00198	0.00271	CbGpPWpGaD
Carfilzomib—PSMB10—Downstream signaling events of B Cell Receptor (BCR)—KRAS—gallbladder cancer	0.00197	0.0027	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—ERBB4—gallbladder cancer	0.00197	0.0027	CbGpPWpGaD
Carfilzomib—PSMB9—Downstream signaling events of B Cell Receptor (BCR)—KRAS—gallbladder cancer	0.00196	0.00269	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—KEAP1—gallbladder cancer	0.00191	0.00263	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—KEAP1—gallbladder cancer	0.00191	0.00263	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—KEAP1—gallbladder cancer	0.00191	0.00263	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—KEAP1—gallbladder cancer	0.00189	0.00259	CbGpPWpGaD
Carfilzomib—PSMB10—Apoptosis—TP53—gallbladder cancer	0.00186	0.00255	CbGpPWpGaD
Carfilzomib—PSMB9—Apoptosis—TP53—gallbladder cancer	0.00185	0.00254	CbGpPWpGaD
Carfilzomib—PSMB10—B Cell Activation—EGFR—gallbladder cancer	0.00184	0.00253	CbGpPWpGaD
Carfilzomib—PSMB9—B Cell Activation—EGFR—gallbladder cancer	0.00183	0.00252	CbGpPWpGaD
Carfilzomib—PSMB5—Cell Cycle Checkpoints—TP53—gallbladder cancer	0.00176	0.00242	CbGpPWpGaD
Carfilzomib—PSMB1—Cell Cycle Checkpoints—TP53—gallbladder cancer	0.00176	0.00242	CbGpPWpGaD
Carfilzomib—PSMB2—Cell Cycle Checkpoints—TP53—gallbladder cancer	0.00176	0.00242	CbGpPWpGaD
Carfilzomib—PSMB10—B Cell Activation—KRAS—gallbladder cancer	0.00174	0.00239	CbGpPWpGaD
Carfilzomib—PSMB8—Cell Cycle Checkpoints—TP53—gallbladder cancer	0.00174	0.00239	CbGpPWpGaD
Carfilzomib—PSMB1—Downstream signaling events of B Cell Receptor (BCR)—NRAS—gallbladder cancer	0.00174	0.00238	CbGpPWpGaD
Carfilzomib—PSMB5—Downstream signaling events of B Cell Receptor (BCR)—NRAS—gallbladder cancer	0.00174	0.00238	CbGpPWpGaD
Carfilzomib—PSMB2—Downstream signaling events of B Cell Receptor (BCR)—NRAS—gallbladder cancer	0.00174	0.00238	CbGpPWpGaD
Carfilzomib—PSMB9—B Cell Activation—KRAS—gallbladder cancer	0.00173	0.00238	CbGpPWpGaD
Carfilzomib—PSMB8—Downstream signaling events of B Cell Receptor (BCR)—NRAS—gallbladder cancer	0.00171	0.00235	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—ERBB3—gallbladder cancer	0.00171	0.00235	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—ERBB3—gallbladder cancer	0.0017	0.00233	CbGpPWpGaD
Carfilzomib—PSMB10—Downstream signaling events of B Cell Receptor (BCR)—HRAS—gallbladder cancer	0.00167	0.0023	CbGpPWpGaD
Carfilzomib—PSMB9—Downstream signaling events of B Cell Receptor (BCR)—HRAS—gallbladder cancer	0.00167	0.00229	CbGpPWpGaD
Carfilzomib—ABCB1—lymph node—gallbladder cancer	0.00163	0.006	CbGeAlD
Carfilzomib—PSMB5—Downstream signaling events of B Cell Receptor (BCR)—EGFR—gallbladder cancer	0.00158	0.00217	CbGpPWpGaD
Carfilzomib—PSMB1—Downstream signaling events of B Cell Receptor (BCR)—EGFR—gallbladder cancer	0.00158	0.00217	CbGpPWpGaD
Carfilzomib—PSMB2—Downstream signaling events of B Cell Receptor (BCR)—EGFR—gallbladder cancer	0.00158	0.00217	CbGpPWpGaD
Carfilzomib—PSMB8—Downstream signaling events of B Cell Receptor (BCR)—EGFR—gallbladder cancer	0.00156	0.00214	CbGpPWpGaD
Carfilzomib—PSMB1—B Cell Activation—NRAS—gallbladder cancer	0.00153	0.0021	CbGpPWpGaD
Carfilzomib—PSMB5—B Cell Activation—NRAS—gallbladder cancer	0.00153	0.0021	CbGpPWpGaD
Carfilzomib—PSMB2—B Cell Activation—NRAS—gallbladder cancer	0.00153	0.0021	CbGpPWpGaD
Carfilzomib—PSMB8—B Cell Activation—NRAS—gallbladder cancer	0.00151	0.00207	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—ERBB4—gallbladder cancer	0.0015	0.00206	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—ERBB4—gallbladder cancer	0.0015	0.00206	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—ERBB4—gallbladder cancer	0.0015	0.00206	CbGpPWpGaD
Carfilzomib—PSMB5—Downstream signaling events of B Cell Receptor (BCR)—KRAS—gallbladder cancer	0.00149	0.00205	CbGpPWpGaD
Carfilzomib—PSMB1—Downstream signaling events of B Cell Receptor (BCR)—KRAS—gallbladder cancer	0.00149	0.00205	CbGpPWpGaD
Carfilzomib—PSMB2—Downstream signaling events of B Cell Receptor (BCR)—KRAS—gallbladder cancer	0.00149	0.00205	CbGpPWpGaD
Carfilzomib—PSMB10—B Cell Activation—HRAS—gallbladder cancer	0.00148	0.00203	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—ERBB4—gallbladder cancer	0.00148	0.00203	CbGpPWpGaD
Carfilzomib—PSMB9—B Cell Activation—HRAS—gallbladder cancer	0.00147	0.00202	CbGpPWpGaD
Carfilzomib—PSMB8—Downstream signaling events of B Cell Receptor (BCR)—KRAS—gallbladder cancer	0.00147	0.00202	CbGpPWpGaD
Carfilzomib—PSMB1—Apoptosis—TP53—gallbladder cancer	0.00141	0.00193	CbGpPWpGaD
Carfilzomib—PSMB5—Apoptosis—TP53—gallbladder cancer	0.00141	0.00193	CbGpPWpGaD
Carfilzomib—PSMB2—Apoptosis—TP53—gallbladder cancer	0.00141	0.00193	CbGpPWpGaD
Carfilzomib—PSMB1—B Cell Activation—EGFR—gallbladder cancer	0.0014	0.00192	CbGpPWpGaD
Carfilzomib—PSMB5—B Cell Activation—EGFR—gallbladder cancer	0.0014	0.00192	CbGpPWpGaD
Carfilzomib—PSMB2—B Cell Activation—EGFR—gallbladder cancer	0.0014	0.00192	CbGpPWpGaD
Carfilzomib—PSMB8—Apoptosis—TP53—gallbladder cancer	0.00139	0.00191	CbGpPWpGaD
Carfilzomib—PSMB8—B Cell Activation—EGFR—gallbladder cancer	0.00138	0.00189	CbGpPWpGaD
Carfilzomib—PSMB5—B Cell Activation—KRAS—gallbladder cancer	0.00132	0.00181	CbGpPWpGaD
Carfilzomib—PSMB1—B Cell Activation—KRAS—gallbladder cancer	0.00132	0.00181	CbGpPWpGaD
Carfilzomib—PSMB2—B Cell Activation—KRAS—gallbladder cancer	0.00132	0.00181	CbGpPWpGaD
Carfilzomib—PSMB8—B Cell Activation—KRAS—gallbladder cancer	0.0013	0.00179	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—ERBB3—gallbladder cancer	0.0013	0.00178	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—ERBB3—gallbladder cancer	0.0013	0.00178	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—ERBB3—gallbladder cancer	0.0013	0.00178	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—ERBB3—gallbladder cancer	0.00128	0.00175	CbGpPWpGaD
Carfilzomib—PSMB5—Downstream signaling events of B Cell Receptor (BCR)—HRAS—gallbladder cancer	0.00127	0.00174	CbGpPWpGaD
Carfilzomib—PSMB1—Downstream signaling events of B Cell Receptor (BCR)—HRAS—gallbladder cancer	0.00127	0.00174	CbGpPWpGaD
Carfilzomib—PSMB2—Downstream signaling events of B Cell Receptor (BCR)—HRAS—gallbladder cancer	0.00127	0.00174	CbGpPWpGaD
Carfilzomib—PSMB8—Downstream signaling events of B Cell Receptor (BCR)—HRAS—gallbladder cancer	0.00125	0.00172	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—ERBB4—gallbladder cancer	0.0012	0.00165	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—ERBB4—gallbladder cancer	0.00119	0.00164	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—NRAS—gallbladder cancer	0.00113	0.00155	CbGpPWpGaD
Carfilzomib—PSMB5—B Cell Activation—HRAS—gallbladder cancer	0.00112	0.00154	CbGpPWpGaD
Carfilzomib—PSMB2—B Cell Activation—HRAS—gallbladder cancer	0.00112	0.00154	CbGpPWpGaD
Carfilzomib—PSMB1—B Cell Activation—HRAS—gallbladder cancer	0.00112	0.00154	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—ERBB4—gallbladder cancer	0.00111	0.00152	CbGpPWpGaD
Carfilzomib—PSMB8—B Cell Activation—HRAS—gallbladder cancer	0.00111	0.00152	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—ERBB4—gallbladder cancer	0.0011	0.00151	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—ERBB2—gallbladder cancer	0.00107	0.00147	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—ERBB2—gallbladder cancer	0.00107	0.00146	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—ERBB3—gallbladder cancer	0.00104	0.00142	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—ERBB3—gallbladder cancer	0.00103	0.00142	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—KRAS—gallbladder cancer	0.000974	0.00134	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—ERBB3—gallbladder cancer	0.000957	0.00131	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—ERBB3—gallbladder cancer	0.000953	0.00131	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—ERBB4—gallbladder cancer	0.000909	0.00125	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—ERBB4—gallbladder cancer	0.000909	0.00125	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—ERBB4—gallbladder cancer	0.000909	0.00125	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—ERBB4—gallbladder cancer	0.000896	0.00123	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—ERBB4—gallbladder cancer	0.000839	0.00115	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—ERBB4—gallbladder cancer	0.000839	0.00115	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—ERBB4—gallbladder cancer	0.000839	0.00115	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—HRAS—gallbladder cancer	0.000828	0.00114	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—ERBB4—gallbladder cancer	0.000827	0.00114	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—NRAS—gallbladder cancer	0.000815	0.00112	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—ERBB2—gallbladder cancer	0.000812	0.00111	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—ERBB2—gallbladder cancer	0.000812	0.00111	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—ERBB2—gallbladder cancer	0.000812	0.00111	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—NRAS—gallbladder cancer	0.000811	0.00111	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—ERBB2—gallbladder cancer	0.000801	0.0011	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—ERBB3—gallbladder cancer	0.000786	0.00108	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—ERBB3—gallbladder cancer	0.000786	0.00108	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—ERBB3—gallbladder cancer	0.000786	0.00108	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—ERBB4—gallbladder cancer	0.000775	0.00106	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—ERBB3—gallbladder cancer	0.000775	0.00106	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—ERBB4—gallbladder cancer	0.000772	0.00106	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—EGFR—gallbladder cancer	0.000743	0.00102	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—EGFR—gallbladder cancer	0.000739	0.00101	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—ERBB3—gallbladder cancer	0.000725	0.000996	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—ERBB3—gallbladder cancer	0.000725	0.000996	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—ERBB3—gallbladder cancer	0.000725	0.000996	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—ERBB3—gallbladder cancer	0.000715	0.000982	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—KRAS—gallbladder cancer	0.000702	0.000963	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—KRAS—gallbladder cancer	0.000698	0.000959	CbGpPWpGaD
Carfilzomib—PSMB10—Cell Cycle—TP53—gallbladder cancer	0.000681	0.000935	CbGpPWpGaD
Carfilzomib—PSMB9—Cell Cycle—TP53—gallbladder cancer	0.000678	0.00093	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—ERBB3—gallbladder cancer	0.00067	0.00092	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—BCL2—gallbladder cancer	0.000669	0.000918	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—ERBB3—gallbladder cancer	0.000667	0.000916	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—BCL2—gallbladder cancer	0.000666	0.000914	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—ERBB2—gallbladder cancer	0.00065	0.000892	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—ERBB2—gallbladder cancer	0.000647	0.000888	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	0.00062	0.000851	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—NRAS—gallbladder cancer	0.000618	0.000848	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—NRAS—gallbladder cancer	0.000618	0.000848	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—NRAS—gallbladder cancer	0.000618	0.000848	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—NRAS—gallbladder cancer	0.000609	0.000836	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	0.000603	0.000827	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—ERBB2—gallbladder cancer	0.0006	0.000824	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—ERBB2—gallbladder cancer	0.000597	0.00082	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—HRAS—gallbladder cancer	0.000596	0.000819	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—HRAS—gallbladder cancer	0.000594	0.000815	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—ERBB4—gallbladder cancer	0.000588	0.000806	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—ERBB4—gallbladder cancer	0.000588	0.000806	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—ERBB4—gallbladder cancer	0.000588	0.000806	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—ERBB4—gallbladder cancer	0.000579	0.000795	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—EGFR—gallbladder cancer	0.000563	0.000773	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—EGFR—gallbladder cancer	0.000563	0.000773	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—EGFR—gallbladder cancer	0.000563	0.000773	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—EGFR—gallbladder cancer	0.000555	0.000762	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—KRAS—gallbladder cancer	0.000532	0.00073	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—KRAS—gallbladder cancer	0.000532	0.00073	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—KRAS—gallbladder cancer	0.000532	0.00073	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—KRAS—gallbladder cancer	0.000524	0.00072	CbGpPWpGaD
Carfilzomib—PSMB1—Cell Cycle—TP53—gallbladder cancer	0.000516	0.000708	CbGpPWpGaD
Carfilzomib—PSMB2—Cell Cycle—TP53—gallbladder cancer	0.000516	0.000708	CbGpPWpGaD
Carfilzomib—PSMB5—Cell Cycle—TP53—gallbladder cancer	0.000516	0.000708	CbGpPWpGaD
Carfilzomib—PSMB8—Cell Cycle—TP53—gallbladder cancer	0.000509	0.000698	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—ERBB3—gallbladder cancer	0.000508	0.000697	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—ERBB3—gallbladder cancer	0.000508	0.000697	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—ERBB3—gallbladder cancer	0.000508	0.000697	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—BCL2—gallbladder cancer	0.000507	0.000696	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—BCL2—gallbladder cancer	0.000507	0.000696	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—BCL2—gallbladder cancer	0.000507	0.000696	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—ERBB3—gallbladder cancer	0.000501	0.000687	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—BCL2—gallbladder cancer	0.0005	0.000686	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—NRAS—gallbladder cancer	0.000495	0.000679	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—ERBB2—gallbladder cancer	0.000493	0.000676	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—ERBB2—gallbladder cancer	0.000493	0.000676	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—ERBB2—gallbladder cancer	0.000493	0.000676	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—NRAS—gallbladder cancer	0.000492	0.000676	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—ERBB2—gallbladder cancer	0.000486	0.000667	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—NRAS—gallbladder cancer	0.000457	0.000627	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—ERBB2—gallbladder cancer	0.000455	0.000624	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—ERBB2—gallbladder cancer	0.000455	0.000624	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—ERBB2—gallbladder cancer	0.000455	0.000624	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—NRAS—gallbladder cancer	0.000454	0.000624	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—HRAS—gallbladder cancer	0.000452	0.00062	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—HRAS—gallbladder cancer	0.000452	0.00062	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—HRAS—gallbladder cancer	0.000452	0.00062	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—EGFR—gallbladder cancer	0.000451	0.000618	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—ERBB2—gallbladder cancer	0.000448	0.000615	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—EGFR—gallbladder cancer	0.000448	0.000615	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—HRAS—gallbladder cancer	0.000446	0.000612	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—KRAS—gallbladder cancer	0.000426	0.000584	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—KRAS—gallbladder cancer	0.000424	0.000581	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—ERBB2—gallbladder cancer	0.00042	0.000577	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—ERBB2—gallbladder cancer	0.000418	0.000574	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	0.000418	0.000573	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—EGFR—gallbladder cancer	0.000416	0.000571	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—EGFR—gallbladder cancer	0.000414	0.000568	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	0.000395	0.000542	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—KRAS—gallbladder cancer	0.000393	0.000539	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—KRAS—gallbladder cancer	0.000391	0.000537	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—NRAS—gallbladder cancer	0.000375	0.000514	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—NRAS—gallbladder cancer	0.000375	0.000514	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—NRAS—gallbladder cancer	0.000375	0.000514	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—NRAS—gallbladder cancer	0.00037	0.000507	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—HRAS—gallbladder cancer	0.000362	0.000497	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—HRAS—gallbladder cancer	0.00036	0.000494	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	0.000351	0.000481	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—NRAS—gallbladder cancer	0.000346	0.000475	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—NRAS—gallbladder cancer	0.000346	0.000475	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—NRAS—gallbladder cancer	0.000346	0.000475	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—EGFR—gallbladder cancer	0.000341	0.000469	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—EGFR—gallbladder cancer	0.000341	0.000469	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—EGFR—gallbladder cancer	0.000341	0.000469	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—NRAS—gallbladder cancer	0.000341	0.000468	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—EGFR—gallbladder cancer	0.000337	0.000462	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—HRAS—gallbladder cancer	0.000334	0.000458	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—HRAS—gallbladder cancer	0.000332	0.000456	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—KRAS—gallbladder cancer	0.000323	0.000443	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—KRAS—gallbladder cancer	0.000323	0.000443	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—KRAS—gallbladder cancer	0.000323	0.000443	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—NRAS—gallbladder cancer	0.00032	0.000439	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—ERBB2—gallbladder cancer	0.000319	0.000437	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—ERBB2—gallbladder cancer	0.000319	0.000437	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—ERBB2—gallbladder cancer	0.000319	0.000437	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—NRAS—gallbladder cancer	0.000318	0.000437	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—KRAS—gallbladder cancer	0.000318	0.000437	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—EGFR—gallbladder cancer	0.000315	0.000433	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—EGFR—gallbladder cancer	0.000315	0.000433	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—EGFR—gallbladder cancer	0.000315	0.000433	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—ERBB2—gallbladder cancer	0.000314	0.000431	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—EGFR—gallbladder cancer	0.000311	0.000427	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—KRAS—gallbladder cancer	0.000298	0.000409	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—KRAS—gallbladder cancer	0.000298	0.000409	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—KRAS—gallbladder cancer	0.000298	0.000409	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—KRAS—gallbladder cancer	0.000294	0.000403	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—EGFR—gallbladder cancer	0.000291	0.0004	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—EGFR—gallbladder cancer	0.00029	0.000398	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—KRAS—gallbladder cancer	0.000275	0.000378	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—HRAS—gallbladder cancer	0.000274	0.000376	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—HRAS—gallbladder cancer	0.000274	0.000376	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—HRAS—gallbladder cancer	0.000274	0.000376	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—KRAS—gallbladder cancer	0.000274	0.000376	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—HRAS—gallbladder cancer	0.00027	0.000371	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—HRAS—gallbladder cancer	0.000253	0.000347	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—HRAS—gallbladder cancer	0.000253	0.000347	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—HRAS—gallbladder cancer	0.000253	0.000347	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—HRAS—gallbladder cancer	0.00025	0.000343	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—TP53—gallbladder cancer	0.000245	0.000336	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—TP53—gallbladder cancer	0.000243	0.000334	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—NRAS—gallbladder cancer	0.000242	0.000333	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—NRAS—gallbladder cancer	0.000242	0.000333	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—NRAS—gallbladder cancer	0.000242	0.000333	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—NRAS—gallbladder cancer	0.000239	0.000328	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—HRAS—gallbladder cancer	0.000234	0.000321	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—HRAS—gallbladder cancer	0.000233	0.00032	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—EGFR—gallbladder cancer	0.000221	0.000303	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—EGFR—gallbladder cancer	0.000221	0.000303	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—EGFR—gallbladder cancer	0.000221	0.000303	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—EGFR—gallbladder cancer	0.000218	0.000299	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—KRAS—gallbladder cancer	0.000209	0.000286	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—KRAS—gallbladder cancer	0.000209	0.000286	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—KRAS—gallbladder cancer	0.000209	0.000286	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—KRAS—gallbladder cancer	0.000206	0.000282	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TP53—gallbladder cancer	0.000185	0.000254	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TP53—gallbladder cancer	0.000185	0.000254	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TP53—gallbladder cancer	0.000185	0.000254	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TP53—gallbladder cancer	0.000183	0.000251	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—HRAS—gallbladder cancer	0.000177	0.000243	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—HRAS—gallbladder cancer	0.000177	0.000243	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—HRAS—gallbladder cancer	0.000177	0.000243	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—HRAS—gallbladder cancer	0.000175	0.00024	CbGpPWpGaD
